Loading...
Tuning protein synthesis for cancer therapy
~50% of colorectal cancers have an activating mutation in KRAS (encoding the KRAS proto-oncogene) and remain difficult to target in the clinic. We have recently shown that activation of KRAS protein alters the regulation of mRNA translation, increasing total protein synthesis, and maintaining elevat...
Na minha lista:
| Udgivet i: | Mol Cell Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8018481/ https://ncbi.nlm.nih.gov/pubmed/33855169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2021.1884034 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|